NFL Biosciences (France) Performance
| ALNFL Stock | 1.45 0.02 1.36% |
On a scale of 0 to 100, NFL Biosciences holds a performance score of 5. The company secures a Beta (Market Risk) of -0.14, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning NFL Biosciences are expected to decrease at a much lower rate. During the bear market, NFL Biosciences is likely to outperform the market. Please check NFL Biosciences' total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether NFL Biosciences' current price movements will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in NFL Biosciences SAS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, NFL Biosciences reported solid returns over the last few months and may actually be approaching a breakup point. ...more
NFL |
NFL Biosciences Relative Risk vs. Return Landscape
If you would invest 129.00 in NFL Biosciences SAS on October 18, 2025 and sell it today you would earn a total of 16.00 from holding NFL Biosciences SAS or generate 12.4% return on investment over 90 days. NFL Biosciences SAS is generating 0.2848% of daily returns and assumes 4.4254% volatility on return distribution over the 90 days horizon. Simply put, 39% of stocks are less volatile than NFL, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
NFL Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NFL Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NFL Biosciences SAS, and traders can use it to determine the average amount a NFL Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0644
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALNFL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.43 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 5 95% of assets perform better |
Based on monthly moving average NFL Biosciences is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NFL Biosciences by adding it to a well-diversified portfolio.
Things to note about NFL Biosciences SAS performance evaluation
Checking the ongoing alerts about NFL Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NFL Biosciences SAS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NFL Biosciences SAS may become a speculative penny stock | |
| NFL Biosciences SAS had very high historical volatility over the last 90 days |
- Analyzing NFL Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NFL Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining NFL Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NFL Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of NFL Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NFL Biosciences' stock. These opinions can provide insight into NFL Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NFL Stock Analysis
When running NFL Biosciences' price analysis, check to measure NFL Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NFL Biosciences is operating at the current time. Most of NFL Biosciences' value examination focuses on studying past and present price action to predict the probability of NFL Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NFL Biosciences' price. Additionally, you may evaluate how the addition of NFL Biosciences to your portfolios can decrease your overall portfolio volatility.